2021-01-11,"Accomplished Biotech Executive Krisztina Zsebo, Ph.D. Joins BioCardias Board of Directors"
2020-12-30,BioCardia Issued New U.S. Patent for Technology that Enhances Control for Cardiac Therapies
2020-12-17,BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Heart Failure Study as Designed
2020-12-16,BioCardia's stock pulls back after taking advantage of recent doubling with another share sale
2020-12-16,"BioCardia, Inc. Announces $10.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules"
2020-12-15,"BioCardia, Inc. Announces $8.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules [Revised]"
2020-12-14,"BioCardia, Inc. Announces $8.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules"
2020-12-14,BioCardia Anticipates DSMB Feedback on Interim Data From Pivotal Phase 3 CardiAMP Heart Failure Trial
2020-12-01,BioCardia Reports Published Study Showing Helix Biotherapeutic Delivery System Used in CardiAMP Phase III Heart Failure Trial Has Fewest Adverse Events Among Competitive Delivery Systems
2020-11-10,BioCardia Reports Third Quarter 2020 Financial Results and Business Highlights
2020-10-26,Published Peer-reviewed Initial Data from BioCardia Pivotal Phase 3 Clinical Trial of CardiAMP Demonstrates Improvement in Heart Failure Patients Measured by Exercise Outcomes and Cardiac Function
2020-10-20,"Read This Before Selling BioCardia, Inc. (NASDAQ:BCDA) Shares"
2020-09-29,BioCardia Issued New Patent for Delivery of Cardiac Cell Therapy Through Wrist Artery
2020-08-31,LD Micro: 360 Companies - Set to Present this Week
2020-08-26,"BioCardia to Present at the LD Micro 500 Virtual Conference on September 1, 2020"
2020-08-13,BioCardia Reports Second Quarter 2020 Financial Results and Business Highlights
2020-08-12,"BioCardia, Inc. (BCDA) May Report Negative Earnings: Know the Trend Ahead of Q2 Release"
2020-08-07,"BioCardia To Conduct Mid-Year Conference Call and Corporate Update August 13, 2020"
2020-08-05,LD Micro - Announces Preliminary List of Presenters for the LD-500.
2020-07-22,"How Much Is BioCardia, Inc. (NASDAQ:BCDA) Paying Its CEO?"
2020-07-01,BioCardia Announces Activation of Pivotal Trial Studying CardiAMP Cell Therapy Trial to Treat Chronic Myocardial Ischemia
2020-07-01,BioCardia Announces CardiAMP Heart Failure Pivotal Trial Continues with First Patient Randomized in COVID-19 Era
2020-06-29,BioCardia Announces CardiAMP Heart Failure Pivotal Trial Continues with First Patient Randomized in COVID-19 Era
2020-06-17,BioCardia Announces Pricing of $10 Million Public Offering
2020-05-15,BioCardia Reports First Quarter 2020 Financial Results and Business Highlights
2020-05-05,BioCardia Announces Positive Preclinical Results Supporting Investigational New Drug Application for Anti-Inflammatory Cell Therapy in Heart Failure
2020-04-30,Biocardia Announces FDA-Recommended Modifications to Primary Endpoint for Cardiamp Cell Therapy Heart Failure Trial to Support Marketing Approval
2020-04-28,BioCardia Awarded New U.S. Patent Covering Helix System for Local Biotherapeutic Delivery of Autologous and Allogenic Cells to the Heart
2020-04-14,"BioCardia Announces Litigation Financing in the Case Captioned Boston Scientific Corp., et al., v. BioCardia Inc."
2020-04-09,BIOCARDIA REPORTS 2019 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS
2020-04-02,"Seasoned Biotech Financial Executive, Jay M. Moyes, Joins Sera Prognostics"
2020-03-31,"BIOCARDIA ANNOUNCES POSITIVE DSMB RECOMMENDATION TO CONTINUE PHASE III PIVOTAL CARDIAMP HEART FAILURE STUDY, AS PLANNED"
2020-03-29,"Should You Take Comfort From Insider Transactions At BioCardia, Inc. (NASDAQ:BCDA)?"
2020-03-12,BIOCARDIA ANNOUNCES TIMING FOR PRESPECIFIED DATA SAFETY MONITORING BOARD REPORT ON PIVOTAL CARDIAMP HEART FAILURE TRIAL
2020-02-13,"Does BioCardia, Inc.'s (NASDAQ:BCDA) CEO Pay Compare Well With Peers?"
2020-01-14,Biocardia Announces FDA Clearance for Morph DNA Deflectable Guide Catheter
2020-01-08,BioCardia Announces New U.S. Patent Covering CardiAMP Cell Therapy and Issuance of Two Asian Patents Covering Radial Artery Approach for Cardiac Cell and Gene Therapy Delivery
2019-12-30,Will BioCardia (NASDAQ:BCDA) Spend Its Cash Wisely?
2019-11-19,BioCardia Reports 2019 Third Quarter Financial Results and Business Highlights
2019-11-11,Investors Who Bought BioCardia (NASDAQ:BCDA) Shares A Year Ago Are Now Down 80%
2019-10-28,BioCardia to Present at Dawson James Securities 5th Annual Small Cap Growth Conference
2019-10-08,BioCardia Receives CE Mark Renewal For Helix Biotherapeutic Delivery Catheter And Morph Guide Catheter Through May 2024
2019-10-02,BioCardia Announces the Appointment of Two New Board Members
2019-10-01,BioCardia Initiates Commercial Release of AVANCE Steerable Introducer Designed to Enhance Physician Control for Complex Cardiac Procedures
2019-09-16,BioCardia Announces Positive DSMB Recommendation to Continue Phase 3 Pivotal CardiAMP Heart Failure Study as Planned
2019-08-21,BioCardia Reports 2019 Second Quarter Financial Results and Business Highlights
2019-08-08,BioCardia Announces Issuance of European Patent for Breakthrough Diagnostic Assay for Patient Selection Prior to Cardiac Cell Therapy Delivery
2019-08-06,BioCardia Announces Closing of $10.0 Million Public Offering
2019-08-02,BioCardia Announces Pricing of $10.0 Million Public Offering and Uplisting to Nasdaq
2019-07-25,BioCardia Signs Exclusive Development Agreement With AstraZeneca
2019-06-12,BioCardia Announces Issuance of Chinese Patent for Image-Guided Biotherapeutic Delivery
2019-06-06,BioCardia Announces Reverse Stock Split and Plan for Listing on a Major Stock Exchange
2019-05-23,Acute Myocardial Infarction Patients Treated Early With Cell Therapy Delivered With BioCardias Helix Endocardial Delivery System Improved in Ejection Fraction and NYHA Class
2019-05-20,BioCardia Reports 2019 First Quarter Financial Results and Business Highlights
2019-05-08,BioCardia Receives FDA Clearance for AVANCE Steerable Introducer for Transseptal Access to Heart
2019-04-02,BioCardia Reports 2018 Financial Results and Recent Business Highlights
